Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2025 ,inter alia, to consider and approve unaudited standalone ....
SOLARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Solara Active Pharma Sciences has informed the stock exchanges that its Board of Directors will meet on Friday, July 25, 2025. The key agenda is to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2025 (Q1 FY26). The filing is a standard regulatory disclosure under SEBI Listing Regulations, with no actual numbers shared at this stage. The company's trading window for insiders is already closed from July 1, 2025, and will remain so until 48 hours after the results are announced.
This is a routine procedural filing and is not expected to move the stock on its own. Investors should watch for the actual Q1 results on July 25, 2025, which will be the first set of quarterly numbers and could drive near-term price action depending on performance versus expectations.